Works matching IS 22351795 AND DT 2020 AND VI 9 AND IP 2
Results: 13
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 1, doi. 10.1159/000507903
- Publication type:
- Article
APPLE News.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 227, doi. 10.1159/000507404
- Publication type:
- Article
A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Comparison of Partial Hepatectomy and Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 138, doi. 10.1159/000505093
- By:
- Publication type:
- Article
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 207, doi. 10.1159/000504650
- By:
- Publication type:
- Article
Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 193, doi. 10.1159/000504604
- By:
- Publication type:
- Article
Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 182, doi. 10.1159/000504548
- By:
- Publication type:
- Article
Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 167, doi. 10.1159/000504252
- By:
- Publication type:
- Article
Microvascular Invasion and a Size Cutoff Value of 2 cm Predict Long-Term Oncological Outcome in Multiple Hepatocellular Carcinoma: Reappraisal of the American Joint Committee on Cancer Staging System and Validation Using the Surveillance, Epidemiology, and End-Results Database
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 156, doi. 10.1159/000504193
- By:
- Publication type:
- Article
Synthetic Lethality Is a Novel and Potential Paradigm for Precision Medicine in Advanced Hepatocellular Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma Patients.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 2, p. 148, doi. 10.1159/000503829
- By:
- Publication type:
- Article
Response to the Comments on Rimassa et al.: "Systemic Treatment Options in Hepatocellular Carcinoma".
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Comprehensive Consideration before the Decision-Making of the Systemic Treatment in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter